Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi

A. Espinel-Ingroff, K. Dawson, M. Pfaller, E. Anaissie, B. Breslin, D. Dixon, A. Fothergill, V. Paetznick, J. Peter, M. Rinaldi, T. Walsh

Research output: Contribution to journalArticle

212 Scopus citations

Abstract

The purpose of the study was to evaluate the interlaboratory agreement of broth dilution susceptibility methods for five species of conidium-forming (size range, 2 to 7 μm) filamentous fungi. The methods used included both macro- and microdilution methods that were adaptations of the proposed reference method of the National Committee for Clinical Laboratory Standards for yeasts (m27-P). The MICs of amphotericin B, fluconazole, itraconazole, miconazole, and ketoconazole were determined in six centers by both macro- and microdilution tests for 25 isolates of Aspergillus flavus, Aspergillus fumigatus, Pseudallescheria boydii, Rhizopus arrhizus, and Sporothrix schenckii. All isolates produced clearly detectable growth within 1 to 4 days at 35Γ in the RPMI 1640 medium. Colony counts of 0.4 x 106 to 3.3 x 106 CFU/ml (mean, 1.4 x 106 CFU/ml) were demonstrated in 90% of the 148 inoculum preparations. Overall, good intralaboratory agreement was demonstrated with amphotericin B, fluconazole, and ketoconazole MICs (90 to 97%). The agreement was lower with itraconazole MICs (59 to 79% median). Interlaboratory reproducibility demonstrated similar results: 90 to 100% agreement with amphotericin B, fluconazole, miconazole, and ketoconazole MICs and 59 to 91% with itraconazole MICs. Among the species tested, the MICs for S. schenckii showed the highest variability. The results of the study imply that it may be possible to develop a reference method for antifungal susceptibility testing of filamentous fungi.

Original languageEnglish (US)
Pages (from-to)314-319
Number of pages6
JournalAntimicrobial agents and chemotherapy
Volume39
Issue number2
StatePublished - Feb 13 1995

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi'. Together they form a unique fingerprint.

  • Cite this

    Espinel-Ingroff, A., Dawson, K., Pfaller, M., Anaissie, E., Breslin, B., Dixon, D., Fothergill, A., Paetznick, V., Peter, J., Rinaldi, M., & Walsh, T. (1995). Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrobial agents and chemotherapy, 39(2), 314-319.